These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 22763930)

  • 1. [Verification of vaccine protection in healthy adults].
    Wolfensberger A; Hatz C; Funk M; Rampini S
    Praxis (Bern 1994); 2012 Jul; 101(14):887-96; quiz 897-8. PubMed ID: 22763930
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vaccination for adults in daily use].
    Frühwein M; Frühwein N
    MMW Fortschr Med; 2011 Jun; 153(23):33-6; quiz 37. PubMed ID: 21692215
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Responsibilities of the general practitioner in vaccination control].
    Wahle K
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S65-70. PubMed ID: 19353474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 1999 to 2002.
    Menzies R; McIntyre P; Beard F
    Commun Dis Intell Q Rep; 2004 Jun; 28 Suppl 1():S1-45. PubMed ID: 16134530
    [No Abstract]   [Full Text] [Related]  

  • 6. [Insufficient vaccination is a threat against world health].
    Gjersvik PJ
    Tidsskr Nor Laegeforen; 2003 Mar; 123(6):831. PubMed ID: 12693127
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosenescence: Implications for vaccination programmes in adults.
    Lang PO; Govind S; Michel JP; Aspinall R; Mitchell WA
    Maturitas; 2011 Apr; 68(4):322-30. PubMed ID: 21316879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical effectiveness and economical evaluation of preventive vaccination].
    Vaz Carneiro A; Belo AI; Gouveia M; Costa J; Borges M
    Acta Med Port; 2011; 24(4):565-86. PubMed ID: 22521015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). NACI update to statement on varicella vaccine.
    National Advisory Committee on Immunization
    Can Commun Dis Rep; 2002 Feb; 28(ACS-3):1-7. PubMed ID: 11875774
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccination and herd immunity: what more do we know?
    Rashid H; Khandaker G; Booy R
    Curr Opin Infect Dis; 2012 Jun; 25(3):243-9. PubMed ID: 22561998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations to improve targeted vaccination coverage among high-risk adults.
    Task Force on Community Preventive Services
    Am J Prev Med; 2005 Jun; 28(5 Suppl):231-7. PubMed ID: 15894158
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 1999 to 2002.
    Menzies R; McIntyre P; Beard F
    Commun Dis Intell Q Rep; 2004; 28(2):127-59. PubMed ID: 15460950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cohort event monitoring to determine the adverse events following administration of mouse brain derived, inactivated Japanese Encephalitis vaccine in an endemic district in Sri Lanka.
    De Alwis KN; Abeysinghe MR; Wickramesinghe AR; Wijesinghe PR
    Vaccine; 2014 Feb; 32(8):924-30. PubMed ID: 24406391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against vaccine-preventable diseases in medical students.
    Baer G; Bonhoeffer J; Schaad UB; Heininger U
    Pediatr Infect Dis J; 2003 Apr; 22(4):373-4. PubMed ID: 12712970
    [No Abstract]   [Full Text] [Related]  

  • 16. Improving the health of Oklahomans through clinical prevention, Part III: Immunizations and chemoprophylaxis.
    Crutcher JM; DeRose DJ; DePersio SR
    J Okla State Med Assoc; 2000 Dec; 93(12):557-66. PubMed ID: 11197951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for measles control in Canada.
    CMAJ; 1988 Mar; 138(6):527-9. PubMed ID: 3345478
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention of infection by vaccination: simple and effective protection].
    Loczenski B
    Pflege Z; 2007 Sep; 60(9):489-92. PubMed ID: 17918607
    [No Abstract]   [Full Text] [Related]  

  • 19. Invasive meningococcal disease epidemiology and control measures: a framework for evaluation.
    Caro JJ; Möller J; Getsios D; Coudeville L; El-Hadi W; Chevat C; Nguyen VH; Caro I
    BMC Public Health; 2007 Jun; 7():130. PubMed ID: 17603880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommended childhood immunization schedule--United States, January-June 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Jan; 44(51-52):940-3. PubMed ID: 8531913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.